Novartis Bioventures Ltd sold $197K of Aeglea Biotherapeutics, Inc.

10% owner

Sold$196,673

$10.06Price

19,550Shares

−1%Stake

What AGLE did after the filing

Prices for AGLE after this filing aren't in yet.

Traded Fri, May 11. Filed Mon, May 14, 12:01 PM ET, during the session. Not investment advice.